NervGen Pharma Corp. (TSXV: NGEN)

NervGen Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21.01	11.66	22.45	16.93	5.6	4.11
Cash & Short-Term Investments	21.01	11.66	22.45	16.93	5.6	4.11
Cash Growth	42.09%	-48.07%	32.62%	202.38%	36.34%	65.95%
Other Receivables	0.01	0.25	0.03	0.06	0.06	0.12
Receivables	0.01	0.25	0.03	0.06	0.06	0.12
Prepaid Expenses	0.17	0.11	0.08	0.07	0.05	0.04
Other Current Assets	0.76	0.5	0.59	0.36	0.49	1.98
Total Current Assets	21.94	12.52	23.15	17.42	6.2	6.26
Property, Plant & Equipment	0	0.2	0.3	0	0	-
Other Intangible Assets	0.48	0.52	0.43	0.47	0.47	0.51
Total Assets	22.46	13.24	23.88	17.9	6.68	6.77
Accounts Payable	0.46	0.55	2	0.35	0.17	0.5
Accrued Expenses	2.93	2.77	1.4	0.73	0.58	0.42
Current Portion of Leases	0.1	0.09	0.09	-	-	-
Other Current Liabilities	9.76	11.73	6.73	-	-	-
Total Current Liabilities	13.25	15.14	10.22	1.08	0.76	0.92
Long-Term Leases	0.03	0.11	0.2	-	-	-
Total Liabilities	13.28	15.25	10.41	1.08	0.76	0.92
Common Stock	80.5	58.93	57.41	42.4	22.95	15.29
Retained Earnings	-93.55	-78.15	-55.77	-35.05	-22.32	-11.14
Comprehensive Income & Other	22.23	17.21	11.82	9.46	5.3	1.68
Shareholders' Equity	9.18	-2.01	13.46	16.82	5.92	5.84
Total Liabilities & Equity	22.46	13.24	23.88	17.9	6.68	6.77
Total Debt	0.13	0.2	0.28	-	-	-
Net Cash (Debt)	20.88	11.46	22.17	16.93	5.6	4.11
Net Cash Growth	43.34%	-48.29%	30.95%	202.38%	36.34%	65.95%
Net Cash Per Share	0.32	0.19	0.42	0.43	0.17	0.16
Filing Date Shares Outstanding	70.31	69.93	59.13	46.23	35.86	29.47
Total Common Shares Outstanding	70.19	59.61	58.78	46.19	35.17	29.35
Working Capital	8.7	-2.62	12.93	16.34	5.45	5.33
Book Value Per Share	0.13	-0.03	0.23	0.36	0.17	0.20
Tangible Book Value	8.7	-2.53	13.03	16.35	5.45	5.33
Tangible Book Value Per Share	0.12	-0.04	0.22	0.35	0.15	0.18

Source: S&P Capital IQ. Standard template. Financial Sources.